ABSTRACT
To evaluate the role of multidetector computed tomography prostatic perfusion in diagnosis of prostate cancer. From November 2007 to December 2009, 112 patients with suspected prostate cancer [with no previous histologic proof of prostate cancer] performed multidetector computed tomography prostatic perfusion followed by TRUS examination results were correlated with histopathological results from TRUS guided biopsy of the prostate were included in this thesis study. Our results are yielding multidetector computed tomography [functional ct "fct"] evaluation for detection of malignancy with sensitivity 90.54%, specificity 86.8%, positive predictive value 93.056%, negative predictive value 82.5%, accuracy 89.3% and pre-test probability = 64.3%. Multidetector computed tomography prostatic perfusion is a sensitive imaging modality the diagnosis of prostate cancer and should be routinely employed for raising the positive predictive value of prostatic biopsy